View this message in a browser

Executive Editor:
 Managing Editor:
Publisher:
Contributing Editors:



Design/Copy Editor:
  CHRISTOPHER PEREZ  
  KENDALL KIRSCH
  NAKINA WEBSTER
  LISA BRAUER
  KARA GOBRON
  ANNE LAMBERT
  ELEANOR ROBERTS
  CAROLYN TIERNEY
What do you want to see in Clinical Compass™?
ASK THE EDITORS
  Last Issue - 07.01.08   Next Issue - 07.29.08  

www.neuroscienceCME.com        
Subscribe to Clinical Compass™ VOLUME 3, ISSUE 15 - JULY 15, 2008
LIVE CME/CE
Multidisciplinary CE Credits Offered!

View our full CME calendar online!

The Impact of Adherence on Maintenance Treatment in Schizophrenia

Satellite Television Broadcast, Webcast, Telephone Simulcast
Premiere Date:
Wednesday, August 6, 2008

MODERATOR
Charles B. Nemeroff, MD, PhD
Charles B. Nemeroff, MD, PhD

FACULTY
Peter F. Buckley, MD
Peter F. Buckley, MD
Diana O. Perkins, MD, MPH
Diana O. Perkins, MD, MPH

Register Now!
Pre-Order Online

Bipolar Depression: Individualizing Treatment to Prevent Relapse and Recurrence

Satellite Television Broadcast, Webcast, Telephone Simulcast
Premiere Date:
Wednesday, September 10, 2008

MODERATOR
Mark A. Frye, MD
Mark A. Frye, MD

FACULTY
Susan L. McElroy, MD
Susan L. McElroy, MD
Roger S. McIntyre, MD, FRCPC
Roger S. McIntyre, MD, FRCPC

Register Now!
Pre-Order Online

SELF-STUDY CME/CE
Multidisciplinary CE Credits Offered!

View our full library of complimentary self-study CE materials!

Excessive Sleepiness: A Neglected Area of Risk?

Webcast
Released: Sunday, September 2, 2007

FACULTY
Ron Grunstein, MB, BS, MD, PhD
Thomas Roth, PhD
David F. Dinges, PhD
Terri E. Weaver, PhD, FAAN, RN


Participate
Order Online

Addressing Clinical Challenges in the Long-Term Treatment of Schizophrenia

Podcast
Released: Friday, February 22, 2008

FACULTY
Charles B. Nemeroff, MD, PhD
Peter F. Buckley, MD
Stephen R. Marder, MD
John W. Newcomer, MD


Participate


FROM THE CLINICAL KNOWLEDGE CENTER:
Managing Mood Disorders in Cancer: A Critical Part of Treating the Whole Patient
 

THIS ISSUE'S COMPASS QUESTIONS™ 

NEW neuroscienceCME TV PREMIERES NEXT MONTH! 

CMEO ADDS 14th & 15th TELLY AWARDS
TO ITS COLLECTION
 


FROM THE CLINICAL KNOWLEDGE CENTER
Managing Mood Disorders in Cancer: A Critical Part of Treating the Whole Patient
Approximately 50 percent of patients with advanced cancer meet criteria for a psychiatric disorder, especially major depressive disorder and anxiety. Mood disorders can be related to the cancer diagnosis itself, the thought of a severe and possibly life-threatening illness, the presence of unpleasant side effects from treatment, disruptions of life plans, diminished quality of life, and the possibility of disease recurrence or progression, etc. Anxiety and/or depression may persist for months or even years following successful cancer treatment...

Read entire article

Back to top


THIS ISSUE'S COMPASS QUESTIONS™
Your responses to this issue's Compass Questions™ will be added to an ongoing needs assessment for educational programming in this important area. Responses to this issue's questions will be reported in an upcoming issue.

Question #1: If a cancer patient with a mood disorder is referred to you, would you provide any different interventions for this patient based on the dual diagnosis?
Yes
No
Sometimes

Question #2: Do you believe that there is a need for education among nonpsychiatric physicians about screening for mood disorders in cancer patients?
Yes
No
Unsure

Question #3: Do you believe that there is a need for education among the psychiatric community about the treatment of mood disorders in cancer patients?
Yes
No
Unsure



Back to top

NEW neuroscienceCME TV
PREMIERES NEXT MONTH!
The Impact of Adherence on Maintenance Treatment
in Schizophrenia

Premiere Date: Wednesday, August 6, 2008
Live Broadcast: 12:00-1:00 p.m. ET
Taped Re-Air: 3:00-4:00 p.m. ET

ACTIVITY GOAL
To describe the importance of remission and recovery as treatment goals in patients with schizophrenia, and to review strategies for optimizing outcomes by employing techniques to improve patient adherence to maintenance pharmacotherapy.

LEARNING OBJECTIVES
At the end of this CE activity, participants should be able to:
  • Define and operationalize remission in schizophrenia.
  • Discuss available data regarding medication nonadherence in patients with schizophrenia.
  • Compare and contrast the efficacy and tolerability of atypical antipsychotics as maintenance therapy.
  • Utilize expert recommendations and evidence to develop individualized treatment plans that improve adherence and outcomes for patients with schizophrenia.
CREDIT INFORMATION
This activity offers CE credit for:
  • Physicians (ACCME/AMA PRA Category 1)
  • Nurses (CNE)
  • Pharmacists (ACPE)
  • Psychologists (APA)
  • Social Workers (NASW)
  • Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.

View Activity Details    Register Now! 

Back to top


CMEO ADDS 14th & 15th TELLY AWARDS TO ITS COLLECTION
CME Outfitters is proud to announce that it has received two Telly Awards in the 29th annual competition for this prestigious award. Presented for outstanding broadcast productions in the area of continuing education, these Telly Awards represent a continuation of CMEO's excellence in this area. This year there were over 14,000 entries in the competition.

Since 2004, CMEO has picked up a total of 15 Tellys for a variety of CME/CE television broadcasts. These most recent awards were earned for the innovative 2-part neuroscienceCME TV series that CMEO developed and produced on the topic of evidence-based medicine:

From Paper to Patient: Applying Clinical Literature to Practice Improvements, Part 1 - Evidence-Based Medicine: Rationale and Conceptual Framework

From Paper to Patient: Applying Clinical Literature to Practice Improvements, Part 2 - Evidence-Based Medicine: Application of Principles to Practice

CMEO would like to recognize the industry supporters who provided educational grants for these activities: AstraZeneca Pharmaceuticals, Eli Lilly and Company, Janssen L.P., and Pfizer Inc.

Congratulations to the CMEO/neuroscienceCME TV team for this tremendous achievement!

Back to top




Problems receiving e-mail from us? Add webmaster@cmeoutfitters.com to your address book.

CME Outfitters, LLC, reserves the right to cancel any activity or make necessary changes in dates, times, speakers, content, and other details without notice. CME Outfitters, LLC, and the commercial supporters of these activities are not responsible for any speaker's or registrant's statements, materials, acts, or omissions.

©2008 CME Outfitters, LLC